Patrick O'Brien, COO at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 50,053 shares at $61.20 ($3.1M) on 2026-01-05, disclosed to the SEC on 2026-01-05.
Seasonal sale ($3.1M) by COO — this insider has traded ARWR in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 560 | $0 | 0.0% |
| 2 | $61.12 | 600 | $37K | 1.2% |
| 3 | $61.20 | 4,368 | $267K | 8.6% |
| 4 | $62.23 | 6,164 | $384K | 12.3% |
| 5 | $62.25 | 900 | $56K | 1.8% |
| 6 | $62.91 | 5,873 |
| $369K |
| 11.8% |
| 7 | $62.96 | 13,451 | $847K | 27.1% |
| 8 | $63.84 | 11,842 | $756K | 24.2% |
| 9 | $64.04 | 2,336 | $150K | 4.8% |
| 10 | $64.44 | 2,700 | $174K | 5.6% |
| 11 | $66.01 | 900 | $59K | 1.9% |
| 12 | $68.00 | 313 | $21K | 0.7% |
| 13 | $68.00 | 46 | $3K | 0.1% |
| Total | $62.40 avg | 50,053 | $3.1M | 100% |
| Filing → |
| ARWR | SELL | 2025-01-07 | $1.3M | — | Filing → |
| ARWR | SELL | 2024-01-05 | $1.9M | — | Filing → |
| ARWR | SELL | 2023-01-06 | $280K | — | Filing → |